P450 interaction with farnesyl-protein transferase inhibitors metabolic stability, inhibitory potency, and P450 binding spectra in human liver microsomes 1 1Abbreviations: FTI, farnesyl-protein transferase inhibitor; FTase, farnesyl-protein transferase; and LC-MS, liquid chromatography-mass spectrometry.-Reference-Cited by-同舟云学术

P450 interaction with farnesyl-protein transferase inhibitors metabolic stability, inhibitory potency, and P450 binding spectra in human liver microsomes 1 1Abbreviations: FTI, farnesyl-protein transferase inhibitor; FTase, farnesyl-protein transferase; and LC-MS, liquid chromatography-mass spectrometry.

Published:2001-09 Issue:6 Volume:62 Page:773-776
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Chiba Masato,Tang Cuyue,Neway William E,Williams Theresa M,Jane Desolms S,Dinsmore Christopher J,Wai John S,Lin Jiunn H

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference21 articles.

1. ras Oncogenes in human cancer;Bos;Cancer Res,1989

2. ras Genes;Barbacid;Annu Rev Biochem,1987

3. Protein isoprenylation and methylation at carboxy-terminal cysteine residues;Clarke;Annu Rev Biochem,1992

4. Potent cell active, non-thiol tetrapeptide inhibitors of farnesyltransferase;Hunt;J Med Chem,1996

5. Structure-activity relationships of cysteine-lacking pentapeptide derivatives that inhibit ras farnesyltransferase;Leonard;J Med Chem,1997

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging trends in small molecule inhibitors targeting aldosterone synthase: A new paradigm in cardiovascular disease treatment;European Journal of Medicinal Chemistry;2024-08

2. A Kinetic Model for Assessing Potential Nitrosamine Carcinogenicity;Chemical Research in Toxicology;2024-07-29

3. Second-Generation Prostaglandin Receptor EP2 Antagonist, TG8-260, with High Potency, Selectivity, Oral Bioavailability, and Anti-Inflammatory Properties;ACS Pharmacology & Translational Science;2022-01-25

4. Discovery of Novel Pyrazole-Based Selective Aldosterone Synthase (CYP11B2) Inhibitors: A New Template to Coordinate the Heme-Iron Motif of CYP11B2;Journal of Medicinal Chemistry;2018-06-07

5. CW EPR parameters reveal cytochrome P450 ligand binding modes;Journal of Inorganic Biochemistry;2018-06